Search

Your search keyword '"Gruslin A"' showing total 843 results

Search Constraints

Start Over You searched for: Author "Gruslin A" Remove constraint Author: "Gruslin A"
843 results on '"Gruslin A"'

Search Results

303. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.

304. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?

305. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.

306. Intrapericardial teratoma in a twin fetus: diagnosis and management

307. Influence of an educational program on medical students' attitudes to substance use disorders in pregnancy.

308. Characterization of IGF-II Isoforms in Binge Eating Disorder and Its Group Psychological Treatment

309. Excessive gestational weight gain and obesity contribute to altered expression of maternal insulin-like growth factor binding protein-3

310. First trimester maternal circulating levels of pregnancy-associated plasma protein A2 (PAPP-A2) are elevated in pregnancies that subsequently develop preeclampsia

311. Maternal serum levels of FGL2 as screening tool for preeclampsia

312. Porous media flow models for maternal placental circulation

314. Obesity and Fetal Programming: How Important Is 9 Months Anyway?

315. The Characterization of Fatty Acid Transport Protein 4 in Third Trimester Placentas from Lean and Obese Pregnancies

316. Maternal Obesity and Excessive Gestational Weight Gain Alter the Maternal-Fetal Insulin-Like Growth Factor Axis

317. Maternal Obesity and Excessive Weight Gain Augment Expression of Maternal Insulin-Like Growth Factor Binding Protein-3

318. Maternal Lipid Metabolism Correlates With Surrogate Markers of Insulin-Like Growth Factor Bioavailability in Maternal and Umbilical Cord Serum

319. SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro

320. Characterization of the holographic imaging grating of GOMOS UVIS spectrometer

321. Characterization of the holographic imaging grating of GOMOS UVIS spectrometer

322. Do coronary bypass graft flows differ between on-pump and off-pump operations?

329. Adverse Fetal and Neonatal Outcomes Associated with a Life-Long High Fat Diet: Role of Altered Development of the Placental Vasculature

330. Prediction of Adverse Maternal Outcomes in Preeclampsia

335. Continuous cold blood cardioplegia improves myocardial protection: a prospective randomized study.

336. Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report

337. No. 96-The Reproductive Care of Women Living With Hepatitis C Infection

338. No96-Sur les soins de santé en reproduction pour les femmes vivant avec l'hépatite C

341. Prediction of Adverse Maternal Outcomes in Preeclampsia: Development and Validation of the FullPIERS Model

343. 434: Sildenafil citrate therapy for early-onset severe intrauterine growth restriction

344. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

345. P32.09: Sonography cervical surveillance with ultrasound-indicated cervical cerclage as compared to prophylatic cerclage in pregnants with clinical risk factors for preterm birth

347. Adverse Fetal and Neonatal Outcomes Associated with a Life-Long High Fat Diet: Role of Altered Development of the Placental Vasculature

348. Reversed umbilical arterial end diastolic flow, sildenafil treatment and early stillbirths

349. 389: Placental biometry and intraplacental villous artery Doppler as predictors of placentally-mediated pregnancy complications

350. [59-OR]: The control of hypertension in pregnancy study (CHIPS) randomized controlled trial – Is the type of antihypertensive important?

Catalog

Books, media, physical & digital resources